Test ID: CTCP
Circulating Tumor Cells (CTC) for Prostate Cancer by CellSearch, Blood
Method Description
Describes how the test is performed and provides a method-specific reference
The CellSearch system consists of a CellTracks AutoPrep System and a CellTracks Analyzer. The AutoPrep system uses a ferrofluid reagent conjugated with monoclonal antibodies to epithelial cell adhesion molecule (EpCAM) to immunomagnetically separate epithelial cells from other blood components. Because the epithelial cell enrichment with EpCAM does not result in a completely pure epithelial cell population, the CellSearch System also utilizes 3 stains (DAPI, anti-cytokeratin, and anti-CD45) to help distinguish true circulating tumor cells (CTCs) from contaminating leukocytes. DAPI stains the nuclei of cells and helps distinguish true cells from nonspecific debris. CTCs are identified with phycoerythrin (PE)-labeled antibodies to cytokeratin (CK) 8, 18, and 19. Leukocytes are identified with allophycocyanin (APC)-labeled antibodies to CD45. Cells that are DAPI+/CD45-/CK+ are considered tumor cells. Cells that are DAPI+ /CD45+/CK- are considered leukocytes. (Package insert: CellSearch Circulating Tumor Cell [CTC]Kit. Veridex, LLC, Raritan, NJ)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Friday, Sunday


